Follow
Yilin Chen
Yilin Chen
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington
Verified email at uw.edu
Title
Cited by
Cited by
Year
Knowledge, attitude, and practice associated with antibiotic use among university students: a survey in Nepal
P Shah, R Shrestha, Z Mao, Y Chen, Y Chen, P Koju, X Liu, H Li
International journal of environmental research and public health 16 (20), 3996, 2019
612019
Association between child abuse and health risk behaviors among Chinese college students
Y Chen, X Liu, Y Huang, H Yu, S Yuan, Y Ye, Q Li, Q He
Journal of child and family studies 26, 1380-1387, 2017
382017
Higher contraceptive uptake in HIV treatment centers offering integrated family planning services: a national survey in Kenya
Y Chen, E Begnel, W Muthigani, D Achwoka, CJ Mcgrath, B Singa, ...
Contraception 102 (1), 39-45, 2020
172020
The health and economic impact of constructing temporary field hospitals to meet the COVID-19 pandemic surge: Wuhan Leishenshan Hospital in China as a case study
Y Cai, Y Chen, L Xiao, S Khor, T Liu, Y Han, Y Yuan, L Cai, G Zeng, ...
Journal of Global Health 11, 2021
152021
Impact of the pilot volume-based drug purchasing policy in China: Interrupted time-series analysis with controls
Y Chen, X Ji, H Xiao, JM Unger, Y Cai, Z Mao, K Yeung
Frontiers in Pharmacology 12, 804237, 2021
142021
Microvascular benefits of new antidiabetic agents: a systematic review and network meta-analysis of kidney outcomes
AS Cha, Y Chen, K Fazioli, MB Rivara, EB Devine
The Journal of Clinical Endocrinology & Metabolism 106 (4), 1225-1234, 2021
112021
An interactive text messaging intervention to improve adherence to option B+ prevention of mother-to-child HIV transmission in Kenya: cost analysis
Y Chen, K Ronen, D Matemo, JA Unger, J Kinuthia, G John-Stewart, ...
JMIR mHealth and uHealth 8 (10), e18351, 2020
72020
Designing a value-based formulary for a commercial health plan: A simulated case study of diabetes medications
Y Chen, AR Loucks, SD Sullivan, SD Pearson, D Kent, K Yeung
Value in Health 26 (7), 1022-1031, 2023
6*2023
Cost-effectiveness analysis of double low-dose budesonide and low-dose budesonide plus montelukast among pediatric patients with persistent asthma receiving Step 3 treatment in …
X Wang, H Fang, K Shen, T Liu, J Xie, Y Liu, P Wu, Y Chen, J Zhong, ...
Journal of Medical Economics 23 (12), 1630-1639, 2020
62020
Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011− 2021
JT Yan, Y Jin, E Lo, Y Chen, AE Hanlon Newell, Y Kong, LJ Inge
Oncology and Therapy 11 (3), 343-360, 2023
52023
Health care costs and resource use of managing hemophilia A: A targeted literature review
Y Chen, SJ Cheng, T Thornhill, P Solari, SD Sullivan
Journal of Managed Care & Specialty Pharmacy 29 (6), 647-658, 2023
52023
Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot
A Jaksa, L Bloudek, JJ Carlson, K Shah, Y Chen, AR Patrick, A McKenna, ...
International journal of technology assessment in health care 38 (1), e32, 2022
42022
Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment
Y Chen, EM Saldarriaga, MA Montano, K Ngure, N Thuo, C Kiptinness, ...
BMJ open 13 (4), e069195, 2023
22023
The effectiveness and value of tirzepatide for type 2 diabetes mellitus: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness …
D Nikitin, GA Lin, JD Campbell, RN Hansen, E Brouwer, Y Chen, ...
Journal of Managed Care & Specialty Pharmacy 28 (6), 680-684, 2022
22022
Performance-based risk-sharing arrangements for devices and diagnostics in the United States: a systematic review
Y Chen, JJ Carlson
Journal of Managed Care & Specialty Pharmacy 28 (1), 78-83, 2022
2*2022
Using machine learning to leverage biomarker change and predict colorectal cancer recurrence
PJ Rodriguez, PJ Heagerty, S Clark, S Khor, Y Chen, E Haupt, EE Hahn, ...
JCO Clinical Cancer Informatics 7, e2300066, 2023
12023
AI2 the impact of including race and ethnicity in risk prediction models on racial bias
S Khor, EE Hahn, EC Haupt, V Shankaran, S Clark, P Rodriguez, Y Chen, ...
Value in Health 24, S1, 2021
12021
Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study
Y Chen, P Martin, LYT Inoue, A Basu, JJ Carlson
Value in Health, 2024
2024
RWD19 Comparative Effectiveness Using External Controls for Single-Arm Trials of Pembrolizumab in Tumor-Agnostic Indications Leveraging Real-World Data
Y Chen, P Martin, S Ye, L Inoue, A Basu, JJ Carlson
Value in Health 26 (6), S363-S364, 2023
2023
MT51 Increased Real-World Biomarker Test Utilization in Patients with Early-Stage Non-Small Cell Lung Cancer in the United States, 2011 to 2021
J Yan, Y Jin, E Lo, Y Chen, HN AE, Y Kong, L Inge
Value in Health 26 (6), S306, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20